Table 3.
The inhibition at 50 μM ligand concentration or half-maximal inhibitory concentrations (IC50) afforded by compounds 1 and 15a-i.
![]() | |||||
---|---|---|---|---|---|
Compound | R | Inhibition (%) at 50 μM | Compound | R | Inhibition (%) at 50 μM |
1 |
![]() |
> 90a | 15e |
![]() |
< 10 |
15a |
![]() |
27 ± 6 | 15f |
![]() |
< 10 |
15b |
![]() |
38 ± 5 | 15g |
![]() |
86 ± 2b |
15c |
![]() |
12 ± 9 | 15h |
![]() |
21 ± 17 |
15d |
![]() |
< 10 | 15i |
![]() |
< 10 |
IC50 2.0 ± 0.1 μM, consistent with previously reported value.14
IC50 4.1 ± 0.3 μM.